Cargando…

Blood DNA methylation and type 2 diabetes mellitus: A protocol for systematic review and meta-analysis

BACKGROUND: Epidemiology of type 2 diabetes (T2D) is affected by genetic and environmental factors. Deoxyribonucleic acid (DNA) methylation as a kind of epigenetic mechanism has been reported to affect the pathogenesis of T2D. Both global DNA methylation and candidate genes were observed differentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xian, Yang, Jiao, Qiu, Xianliang, Wen, Qing, Liu, Min, Chen, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306281/
https://www.ncbi.nlm.nih.gov/pubmed/32502009
http://dx.doi.org/10.1097/MD.0000000000020530
_version_ 1783548622947745792
author Wang, Xian
Yang, Jiao
Qiu, Xianliang
Wen, Qing
Liu, Min
Chen, Qiu
author_facet Wang, Xian
Yang, Jiao
Qiu, Xianliang
Wen, Qing
Liu, Min
Chen, Qiu
author_sort Wang, Xian
collection PubMed
description BACKGROUND: Epidemiology of type 2 diabetes (T2D) is affected by genetic and environmental factors. Deoxyribonucleic acid (DNA) methylation as a kind of epigenetic mechanism has been reported to affect the pathogenesis of T2D. Both global DNA methylation and candidate genes were observed differentially methylated and identified changes. Peripheral blood biomarkers could have significant clinical utility due to the noninvasive operation and showed efficacy in measuring T2D-related DNA methylation. Moreover, due to the reversible feature of DNA methylation, it can be an effective therapy for T2D. METHODS: This study will be conducted according to the preferred reporting items for systematic review and meta-analysis protocols 2015 statement. The protocol of this systematic review and meta-analysis was registered on international platform of registered systematic review and meta-analysis protocols (No. 202040136). The following electronic bibliographic databases will be searched from inception: EMBASE, MEDLINE, Web of Science, Cochrane Central, China National Knowledge Infrastructure, Wanfang and China Science and Technology Journal Database, and Clinical Trials (ClinicalTrials.gov). A search strategy will be developed using a combination of medical subheadings words and keywords related to T2D, human peripheral blood, and DNA methylation. Two reviewers will screen the literature, and a third reviewer will adjudicate in case of disagreements. All the data will be extracted by 2 independent reviewers. The Cochrane Risk of Bias Assessment Tool will be used to assess the bias of randomized controlled studies, and the Newcastle–Ottawa scale for nonrandomized controlled studies. All the assessment will be investigated by 2 independent reviewers. The overall quality of extracted data will be assessed by using the grading of recommendations, assessment, development, and evaluation assessment tool. Disagreements and conflicts will be resolved by discussing it with a third reviewer. The narrative synthesis and meta-analysis of all evidence will be performed as the main findings analyzed.
format Online
Article
Text
id pubmed-7306281
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-73062812020-07-08 Blood DNA methylation and type 2 diabetes mellitus: A protocol for systematic review and meta-analysis Wang, Xian Yang, Jiao Qiu, Xianliang Wen, Qing Liu, Min Chen, Qiu Medicine (Baltimore) 4300 BACKGROUND: Epidemiology of type 2 diabetes (T2D) is affected by genetic and environmental factors. Deoxyribonucleic acid (DNA) methylation as a kind of epigenetic mechanism has been reported to affect the pathogenesis of T2D. Both global DNA methylation and candidate genes were observed differentially methylated and identified changes. Peripheral blood biomarkers could have significant clinical utility due to the noninvasive operation and showed efficacy in measuring T2D-related DNA methylation. Moreover, due to the reversible feature of DNA methylation, it can be an effective therapy for T2D. METHODS: This study will be conducted according to the preferred reporting items for systematic review and meta-analysis protocols 2015 statement. The protocol of this systematic review and meta-analysis was registered on international platform of registered systematic review and meta-analysis protocols (No. 202040136). The following electronic bibliographic databases will be searched from inception: EMBASE, MEDLINE, Web of Science, Cochrane Central, China National Knowledge Infrastructure, Wanfang and China Science and Technology Journal Database, and Clinical Trials (ClinicalTrials.gov). A search strategy will be developed using a combination of medical subheadings words and keywords related to T2D, human peripheral blood, and DNA methylation. Two reviewers will screen the literature, and a third reviewer will adjudicate in case of disagreements. All the data will be extracted by 2 independent reviewers. The Cochrane Risk of Bias Assessment Tool will be used to assess the bias of randomized controlled studies, and the Newcastle–Ottawa scale for nonrandomized controlled studies. All the assessment will be investigated by 2 independent reviewers. The overall quality of extracted data will be assessed by using the grading of recommendations, assessment, development, and evaluation assessment tool. Disagreements and conflicts will be resolved by discussing it with a third reviewer. The narrative synthesis and meta-analysis of all evidence will be performed as the main findings analyzed. Wolters Kluwer Health 2020-06-05 /pmc/articles/PMC7306281/ /pubmed/32502009 http://dx.doi.org/10.1097/MD.0000000000020530 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4300
Wang, Xian
Yang, Jiao
Qiu, Xianliang
Wen, Qing
Liu, Min
Chen, Qiu
Blood DNA methylation and type 2 diabetes mellitus: A protocol for systematic review and meta-analysis
title Blood DNA methylation and type 2 diabetes mellitus: A protocol for systematic review and meta-analysis
title_full Blood DNA methylation and type 2 diabetes mellitus: A protocol for systematic review and meta-analysis
title_fullStr Blood DNA methylation and type 2 diabetes mellitus: A protocol for systematic review and meta-analysis
title_full_unstemmed Blood DNA methylation and type 2 diabetes mellitus: A protocol for systematic review and meta-analysis
title_short Blood DNA methylation and type 2 diabetes mellitus: A protocol for systematic review and meta-analysis
title_sort blood dna methylation and type 2 diabetes mellitus: a protocol for systematic review and meta-analysis
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306281/
https://www.ncbi.nlm.nih.gov/pubmed/32502009
http://dx.doi.org/10.1097/MD.0000000000020530
work_keys_str_mv AT wangxian blooddnamethylationandtype2diabetesmellitusaprotocolforsystematicreviewandmetaanalysis
AT yangjiao blooddnamethylationandtype2diabetesmellitusaprotocolforsystematicreviewandmetaanalysis
AT qiuxianliang blooddnamethylationandtype2diabetesmellitusaprotocolforsystematicreviewandmetaanalysis
AT wenqing blooddnamethylationandtype2diabetesmellitusaprotocolforsystematicreviewandmetaanalysis
AT liumin blooddnamethylationandtype2diabetesmellitusaprotocolforsystematicreviewandmetaanalysis
AT chenqiu blooddnamethylationandtype2diabetesmellitusaprotocolforsystematicreviewandmetaanalysis